Testosterone exposure in childhood: discerning pathology from physiology

Bibliography

• Blecher SR, Erickson RP. Genetics of sexual development: a new paradigm. Am J Med Genet A 2007;143A(24):3054-68
   PubMed Web of Science ®Google Scholar
• Brennan J, Capel B. One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nat Rev Genet 2004;5(7):509-21
   PubMed Web of Science ®Google Scholar
• Wilhelm D, Koopman P. The makings of maleness: towards an integrated view of male sexual development. Nat Rev Genet 2006;7(8):620-31
   PubMed Web of Science ®Google Scholar
• Gubbay J, Collignon J, Koopman P, A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 1990;346(6281):245-50
   PubMed Web of Science ®Google Scholar
• Sinclair AH, Berta P, Palmer MS, A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990;346(6281):240-4
   PubMed Web of Science ®Google Scholar
• Yucel S, Cavalcanti AG, Wang Z, Baskin LS. The impact of prenatal androgens on vaginal and urogenital sinus development in the female mouse. J Urol 2003;170(4 Pt 1):1432-6
   PubMed Web of Science ®Google Scholar
• Ogilvy-Stuart AL, Brain CE. Early assessment of ambiguous genitalia. Arch Dis Child 2004;89(5):401-7
   PubMed Web of Science ®Google Scholar
• Speiser PW, Azziz R, Baskin LS, Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2010;95(9):4133-60
   PubMed Web of Science ®Google Scholar
• Trapp CM, Speiser PW, Oberfield SE. Congenital adrenal hyperplasia: an update in children. Curr Opin Endocrinol Diabetes Obes 2011;18(3):166-70
   PubMed Web of Science ®Google Scholar
• Hughes I. Congenital adrenal hyperplasia: phenotype and genotype. J Pediatr Endocrinol Metab 2002;15(Suppl 5):1329-40
   PubMedGoogle Scholar
• Dolzan V, Solyom J, Fekete G, Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol 2005;153(1):99-106
   PubMed Web of Science ®Google Scholar
• Einaudi S, Napolitano E, Restivo F, Genotype, phenotype and hormonal levels correlation in non-classical congenital adrenal hyperplasia. J Endocrinol Invest 2011;34(9):660-4
   PubMed Web of Science ®Google Scholar
• Belgorosky A, Pepe C, Marino R, Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterozygote for two new point mutations of the CYP19 gene. J Clin Endocrinol Metab 2003;88(11):5127-31
   PubMed Web of Science ®Google Scholar
• Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab 1991;72(3):560-6
   PubMed Web of Science ®Google Scholar
• Conte FA, Grumbach MM, Ito Y, A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 1994;78(6):1287-92
   PubMed Web of Science ®Google Scholar
• Belgorosky A, Guercio G, Pepe C, Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence. Horm Res 2009;72(6):321-30
   PubMed Web of Science ®Google Scholar
• Morishima A, Grumbach MM, Simpson ER, Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80(12):3689-98
   PubMed Web of Science ®Google Scholar
• Mullis PE, Yoshimura N, Kuhlmann B, Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab 1997;82(6):1739-45
   PubMed Web of Science ®Google Scholar
• Carani C, Qin K, Simoni M, Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997;337(2):91-5
   PubMed Web of Science ®Google Scholar
• Lee PA, Houk CP, Ahmed SF, Hughes IA; International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. international consensus conference on intersex. Pediatrics 2006;118(2):e488-500
   PubMed Web of Science ®Google Scholar
• Sir-Petermann T, Maliqueo M, Angel B, Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002;17(10):2573-9
   PubMed Web of Science ®Google Scholar
• Bilowus M, Abbassi V, Gibbons MD. Female pseudohermaphroditism in a neonate born to a mother with polycystic ovarian disease. J Urol 1986;136(5):1098-100
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit A, Greenblatt EM. Recurrent maternal virilization during pregnancy associated with polycystic ovarian syndrome: a case report and review of the literature. Hum Reprod 1995;10(11):3057-60
   PubMed Web of Science ®Google Scholar
• Bertalan R, Csabay L, Blazovics A, Maternal hyperandrogenism beginning from early pregnancy and progressing until delivery does not produce virilization of a female newborn. Gynecol Endocrinol 2007;23(10):581-3
   PubMed Web of Science ®Google Scholar
• Krone N, Wachter I, Stefanidou M, Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin Endocrinol (Oxf) 2001;55(4):523-9
   PubMed Web of Science ®Google Scholar
• Dumic M, Janjanin N, Ille J, Pregnancy outcomes in women with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 2005;18(9):887-95
   PubMed Web of Science ®Google Scholar
• Pascal RR, Grecco LA. Mucinous cystadenoma of the ovary with stromal luteinization and hilar cell hyperplasia during pregnancy. Hum Pathol 1988;19(2):179-80
   PubMed Web of Science ®Google Scholar
• Choi JR, Levine D, Finberg H. Luteoma of pregnancy: sonographic findings in two cases. J Ultrasound Med 2000;19(12):877-81
   PubMed Web of Science ®Google Scholar
• Clement PB. Tumor-like lesions of the ovary associated with pregnancy. Int J Gynecol Pathol 1993;12(2):108-15
   PubMed Web of Science ®Google Scholar
• Tan ML, Lam SL, Nadarajah S. Pregnancy luteoma presenting as ovarian torsion with rupture and intra-abdominal bleeding. Singapore Med J 2008;49(3):e78-81
   PubMed Web of Science ®Google Scholar
• Spitzer RF, Wherrett D, Chitayat D, Maternal luteoma of pregnancy presenting with virilization of the female infant. J Obstet Gynaecol Can 2007;29(10):835-40
   PubMedGoogle Scholar
• Brunskill PJ. The effects of fetal exposure to danazol. Br J Obstet Gynaecol 1992;99(3):212-15
   PubMedGoogle Scholar
• Rosa FW. Virilization of the female fetus with maternal danazol exposure. Am J Obstet Gynecol 1984;149(1):99-100
   PubMed Web of Science ®Google Scholar
• Cohen-Kettenis P. Psychological long-term outcome in intersex conditions. Horm Res 2005;64(Suppl 2):27-30
   PubMed Web of Science ®Google Scholar
• Reiner WG. Gender identity and sex-of-rearing in children with disorders of sexual differentiation. J Pediatr Endocrinol Metab 2005;18(6):549-53
   PubMed Web of Science ®Google Scholar
• Lee PA, Houk CP. Review of outcome information in 46,XX patients with congenital adrenal hyperplasia assigned/reared male: what does it say about gender assignment? Int J Pediatr Endocrinol 2010;2010:982025
   PubMedGoogle Scholar
• Houk CP, Lee PA. Approach to assigning gender in 46,XX congenital adrenal hyperplasia with male external genitalia: replacing dogmatism with pragmatism. J Clin Endocrinol Metab 2010;95(10):4501-8
   PubMed Web of Science ®Google Scholar
• Berenbaum SA, Duck SC, Bryk K. Behavioral effects of prenatal versus postnatal androgen excess in children with 21-hydroxylase-deficient congenital adrenal hyperplasia. J Clin Endocrinol Metab 2000;85(2):727-33
   PubMed Web of Science ®Google Scholar
• Berenbaum SA. Effects of early androgens on sex-typed activities and interests in adolescents with congenital adrenal hyperplasia. Horm Behav 1999;35(1):102-10
   PubMed Web of Science ®Google Scholar
• Dittmann RW, Kappes ME, Kappes MH. Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia. Psychoneuroendocrinology 1992;17(2-3):153-70
   PubMed Web of Science ®Google Scholar
• Beltz AM, Swanson JL, Berenbaum SA. Gendered occupational interests: prenatal androgen effects on psychological orientation to things versus people. Horm Behav 2011;60(4):313-17
   PubMed Web of Science ®Google Scholar
• Mathews GA, Fane BA, Conway GS, Personality and congenital adrenal hyperplasia: possible effects of prenatal androgen exposure. Horm Behav 2009;55(2):285-91
   PubMed Web of Science ®Google Scholar
• Zucker KJ, Bradley SJ, Oliver G, Psychosexual development of women with congenital adrenal hyperplasia. Horm Behav 1996;30(4):300-18
   PubMed Web of Science ®Google Scholar
• Winter JS, Hughes IA, Reyes FI, Faiman C. Pituitary-gonadal relations in infancy: 2. patterns of serum gonadal steroid concentrations in man from birth to two years of age. J Clin Endocrinol Metab 1976;42(4):679-86
   PubMed Web of Science ®Google Scholar
• Schmidt H, Schwarz HP. Serum concentrations of LH and FSH in the healthy newborn. Eur J Endocrinol 2000;143(2):213-15
   PubMed Web of Science ®Google Scholar
• Kuiri-Hanninen T, Seuri R, Tyrvainen E, Increased activity of the hypothalamic-pituitary-testicular axis in infancy results in increased androgen action in premature boys. J Clin Endocrinol Metab 2011;96(1):98-105
   PubMed Web of Science ®Google Scholar
• Boas M, Boisen KA, Virtanen HE, Postnatal penile length and growth rate correlate to serum testosterone levels: a longitudinal study of 1962 normal boys. Eur J Endocrinol 2006;154(1):125-9
   PubMed Web of Science ®Google Scholar
• Sun SS, Schubert CM, Chumlea WC, National estimates of the timing of sexual maturation and racial differences among US children. Pediatrics 2002;110(5):911-19
   PubMed Web of Science ®Google Scholar
• Chemaitilly W, Trivin C, Adan L, Central precocious puberty: clinical and laboratory features. Clin Endocrinol (Oxf) 2001;54(3):289-94
   PubMed Web of Science ®Google Scholar
• Houchin LD, Rogol AD. Androgen replacement in children with constitutional delay of puberty: the case for aggressive therapy. Baillieres Clin Endocrinol Metab 1998;12(3):427-40
   PubMed Web of Science ®Google Scholar
• Davenport ML. Growth hormone therapy in turner syndrome. Pediatr Endocrinol Rev 2012;9(Suppl 2):723-4
   PubMedGoogle Scholar
• Gault EJ, Perry RJ, Cole TJ, Effect of oxandrolone and timing of pubertal induction on final height in turner's syndrome: randomised, double blind, placebo controlled trial. BMJ 2011;342:d1980
   PubMedGoogle Scholar
• Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome. J Clin Endocrinol Metab 2010;95(3):1151-60
   PubMed Web of Science ®Google Scholar
• Zeger MP, Shah K, Kowal K, Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with turner syndrome. Horm Res Paediatr 2011;75(1):38-46
   PubMed Web of Science ®Google Scholar
• Freriks K, Sas TC, Traas MA, Long-term effects of previous oxandrolone treatment in adult women with turner syndrome. Eur J Endocrinol 2012;168(1):91-9
   PubMed Web of Science ®Google Scholar
• Rosenfeld RG, Attie KM, Frane J, Growth hormone therapy of turner's syndrome: beneficial effect on adult height. J Pediatr 1998;132(2):319-24
   PubMed Web of Science ®Google Scholar
• Nilsson KO, Albertsson-Wikland K, Alm J, Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab 1996;81(2):635-40
   PubMed Web of Science ®Google Scholar
• Stahnke N, Keller E, Landy H; Serono Study Group. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. J Pediatr Endocrinol Metab 2002;15(2):129-38
   PubMed Web of Science ®Google Scholar
• Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome. J Clin Endocrinol Metab 2010;95(3):1151-60
   PubMed Web of Science ®Google Scholar
• Rogol AD, Tartaglia N. Considerations for androgen therapy in children and adolescents with Klinefelter syndrome (47, XXY). Pediatr Endocrinol Rev 2010;8(Suppl 1):145-50
   PubMedGoogle Scholar
• Samango-Sprouse CA, Gropman AL, Sadeghin T, Effects of short-course androgen therapy on the neurodevelopmental profile of infants and children with 49,XXXXY syndrome. Acta Paediatr 2011;100(6):861-5
   PubMed Web of Science ®Google Scholar
• Menke LA, Sas TC, Visser M, The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with turner syndrome. Horm Behav 2010;57(3):297-305
   PubMed Web of Science ®Google Scholar
• Ross JL, Roeltgen D, Stefanatos GA, Androgen-responsive aspects of cognition in girls with turner syndrome. J Clin Endocrinol Metab 2003;88(1):292-6
   PubMed Web of Science ®Google Scholar
• Ross JL, Mazzocco MM, Kushner H, Effects of treatment with oxandrolone for 4 years on the frequency of severe arithmetic learning disability in girls with turner syndrome. J Pediatr 2009;155(5):714-20
   PubMed Web of Science ®Google Scholar
• Bhasin S, Cunningham GR, Hayes FJ, Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2010;95(6):2536-59
   PubMed Web of Science ®Google Scholar
• Nieschlag E. Testosterone treatment comes of age: new options for hypogonadal men. Clin Endocrinol (Oxf) 2006;65(3):275-81
   PubMed Web of Science ®Google Scholar
• Rogol AD. New facets of androgen replacement therapy during childhood and adolescence. Expert Opin Pharmacother 2005;6(8):1319-36
   PubMed Web of Science ®Google Scholar
• Drobac S, Rubin K, Rogol AD, Rosenfield RL. A workshop on pubertal hormone replacement options in the united states. J Pediatr Endocrinol Metab 2006;19(1):55-64
   PubMed Web of Science ®Google Scholar
• de Ronde W. Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies. Hum Reprod 2009;24(2):425-8
   PubMed Web of Science ®Google Scholar
• Rolf C, Knie U, Lemmnitz G, Nieschlag E. Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation. Clin Endocrinol (Oxf) 2002;56(5):637-41
   PubMed Web of Science ®Google Scholar
• Stahlman J, Britto M, Fitzpatrick S, Effect of application site, clothing barrier, and application site washing on testosterone transfer with a 1.62% testosterone gel. Curr Med Res Opin 2012;28(2):281-90
   PubMed Web of Science ®Google Scholar
• Stahlman J, Britto M, Fitzpatrick S, Serum testosterone levels in non-dosed females after secondary exposure to 1.62% testosterone gel: effects of clothing barrier on testosterone absorption. Curr Med Res Opin 2012;28(2):291-30
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Testosterone gel safety concerns prompt FDA to require label changes, medication guide. 2009. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149580.htm [Cited 4 January 2013]
   Google Scholar
• Yu YM, Punyasavatsu N, Elder D, D'Ercole AJ. Sexual development in a two-year-old boy induced by topical exposure to testosterone. Pediatrics 1999;104(2):e23
   PubMedGoogle Scholar
• Kunz GJ, Klein KO, Clemons RD, Virilization of young children after topical androgen use by their parents. Pediatrics 2004;114(1):282-4
   PubMed Web of Science ®Google Scholar
• Cavender RK, Fairall M. Precocious puberty secondary to topical testosterone transfer: a case report. J Sex Med 2011;8(2):622-6
   PubMed Web of Science ®Google Scholar
• Brachet C, Vermeulen J, Heinrichs C. Children's virilization and the use of a testosterone gel by their fathers. Eur J Pediatr 2005;164(10):646-7
   PubMed Web of Science ®Google Scholar
• Franklin SL, Geffner ME. Precocious puberty secondary to topical testosterone exposure. J Pediatr Endocrinol Metab 2003;16(1):107-10
   PubMed Web of Science ®Google Scholar
• Bhowmick SK, Ricke T, Rettig KR. Sexual precocity in a 16-month-old boy induced by indirect topical exposure to testosterone. Clin Pediatr (Phila) 2007;46(6):540-3
   PubMed Web of Science ®Google Scholar
• Merhi ZO, Santoro N. Postmenopausal virilization after spousal use of topical androgens. Fertil Steril 2007;87(4):976; e13,976.e15
   PubMedGoogle Scholar
• von Oettingen J, Sola Pou J, Levitsky LL, Misra M. Clinical presentation of children with premature adrenarche. Clin Pediatr (Phila) 2012;51(12):1140-9
   PubMed Web of Science ®Google Scholar
• Williams RM, Ward CE, Hughes IA. Premature adrenarche. Arch Dis Child 2012;97(3):250-4
   PubMed Web of Science ®Google Scholar
• Ribeiro RC, Pinto EM, Zambetti GP. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies. Best Pract Res Clin Endocrinol Metab 2010;24(3):477-90
   PubMed Web of Science ®Google Scholar
• Chen QL, Su Z, Li YH, Clinical characteristics of adrenocortical tumors in children. J Pediatr Endocrinol Metab 2011;24(7-8):535-41
   PubMed Web of Science ®Google Scholar
• Jaruratanasirikul S, Patarapinyokul S, Mitranun W. Androgen-producing adrenocortical carcinoma: report of 3 cases with different clinical presentations. J Med Assoc Thai 2012;95(6):816-20
   PubMedGoogle Scholar
• Ribeiro RC, Pinto EM, Zambetti GP, Rodriguez-Galindo C. The international pediatric adrenocortical tumor registry initiative: contributions to clinical, biological, and treatment advances in pediatric adrenocortical tumors. Mol Cell Endocrinol 2012;351(1):37-43
   PubMed Web of Science ®Google Scholar
• Richter-Unruh A, Wessels HT, Menken U, Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. J Clin Endocrinol Metab 2002;87(3):1052-6
   Google Scholar
• Lignitz S, Partsch CJ, Wudy SA, Clinical and metabolic findings in a 6-year-old boy with a Leydig cell tumour. Acta Paediatr 2011;100(12):e280-2
   PubMed Web of Science ®Google Scholar
• Olivier P, Simoneau-Roy J, Francoeur D, Leydig cell tumors in children: contrasting clinical, hormonal, anatomical, and molecular characteristics in boys and girls. J Pediatr 2012;161(6):1147-52
   PubMed Web of Science ®Google Scholar
• Charmandari E, Kino T, Chrousos GP. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Ann NY Acad Sci 2004;1024:168-81
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91(2):456-88
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006;91(11):4237-45
   PubMed Web of Science ®Google Scholar
• Bekx MT, Connor EC, Allen DB. Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome. J Pediatr Adolesc Gynecol 2010;23(1):7-10
   PubMed Web of Science ®Google Scholar
• Bremer AA. Polycystic ovary syndrome in the pediatric population. Metab Syndr Relat Disord 2010;8(5):375-94
   PubMed Web of Science ®Google Scholar
• Ojaniemi M, Tapanainen P, Morin-Papunen L. Management of polycystic ovary syndrome in childhood and adolescence. Horm Res Paediatr 2010;74(5):372-5
   PubMed Web of Science ®Google Scholar
• Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010;8:41; 7015-8-41
   PubMed Web of Science ®Google Scholar
• Rackow BW. Polycystic ovary syndrome in adolescents. Curr Opin Obstet Gynecol 2012;24(5):281-7
   PubMed Web of Science ®Google Scholar
• Cecchetto G, Ferrari A, Bernini G, Sex cord stromal tumors of the ovary in children: a clinicopathological report from the Italian TREP project. Pediatr Blood Cancer 2011;56(7):1062-7
   PubMed Web of Science ®Google Scholar
• Egli CA, Rosenthal SM, Grumbach MM, Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis. J Pediatr 1985;106(1):33-40
   PubMed Web of Science ®Google Scholar
• Haddad N, Eugster E. An update on the treatment of precocious puberty in McCune-Albright syndrome and testotoxicosis. J Pediatr Endocrinol Metab 2007;20(6):653-61
   PubMed Web of Science ®Google Scholar
• Lenz AM, Shulman D, Eugster EA, Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics 2010;126(3):e728-33
   PubMed Web of Science ®Google Scholar
• Soriano-Guillen L, Lahlou N, Chauvet G, Adult height after ketoconazole treatment in patients with familial male-limited precocious puberty. J Clin Endocrinol Metab 2005;90(1):147-51
   Google Scholar
• Soriano-Guillen L, Mitchell V, Carel JC, Activating mutations in the luteinizing hormone receptor gene: a human model of non-follicle-stimulating hormone-dependent inhibin production and germ cell maturation. J Clin Endocrinol Metab 2006;91(8):3041-7
   Google Scholar
• Mamkin I, Philibert P, Anhalt H, Unusual phenotypical variations in a boy with McCune-Albright syndrome. Horm Res Paediatr 2010;73(3):215-22
   PubMed Web of Science ®Google Scholar
• Boyce AM, Chong WH, Shawker TH, Characterization and management of testicular pathology in McCune-Albright syndrome. J Clin Endocrinol Metab 2012;97(9):E1782-90
   PubMed Web of Science ®Google Scholar
• de Monleon JV, Simonin G, Pincemaille O, Precocious puberty secondary to an intramedullary germinoma. Arch Pediatr 1999;6(1):46-9
   PubMedGoogle Scholar
• Starzyk J, Starzyk B, Bartnik-Mikuta A, Gonadotropin releasing hormone-independent precocious puberty in a 5 year-old girl with suprasellar germ cell tumor secreting beta-hCG and alpha-fetoprotein. J Pediatr Endocrinol Metab 2001;14(6):789-96
   PubMed Web of Science ®Google Scholar
• Patel A, Rivkees SA. Prenatal virilization associated with paternal testosterone gel therapy. Int J Pediatr Endocrinol 2010;2010:867471
   PubMedGoogle Scholar